Journal of neuroimmunologyHumansFemaleMaleAdultGlial Fibrillary Acidic Protein
Comparison of SIMOA and VEUS technologies for serum glial fibrillary acidic protein measurement.
Radovan Bunganic, Kamila Zondra Revendova, Pavel Hradilek, Pavlina Kusnierova
Published: 202610.1016/j.jneuroim.2025.578825
Abstract
INTRODUCTION: Serum glial fibrillary acidic protein (sGFAP) is increasingly studied as a biomarker of astroglial injury, but comparative data between ultra-sensitive analytical platforms are limited. This study evaluated the agreement between the new…
Preview only. Read the full abstract at the source